Citation Impact

Citing Papers

New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Treatment of kidney cancer
2009 StandoutNobel
Synthetic lethality: a framework for the development of wiser cancer therapeutics
2009 StandoutNobel
Molecular imaging in drug development
2008 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib
2006
Gastrointestinal stromal tumour
2007
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
2010 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
2008
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Promise and pitfalls of quantitative imaging in oncology clinical trials
2012
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
2005
Intraoperative Multispectral Fluorescence Imaging for the Detection of the Sentinel Lymph Node in Cervical Cancer: A Novel Concept
2010
Defining the Role of mTOR in Cancer
2007 Standout
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
2010
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
The PI3K Pathway in Human Disease
2017 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Meta-analysis
2011
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Use of PET for monitoring cancer therapy and for predicting outcome.
2005
von Hippel-Lindau Disease
2006 StandoutNobel
Positron Emission Tomography As an Imaging Biomarker
2006
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
2007
CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal Tumor
2007
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective
2016
Absence of Progression As Assessed by Response Evaluation Criteria in Solid Tumors Predicts Survival in Advanced GI Stromal Tumors Treated With Imatinib Mesylate: The Intergroup EORTC-ISG-AGITG Phase III Trial
2009
Agonist−Antagonist Dilemma in Molecular Imaging: Evaluation of a Monomolecular Multimodal Imaging Agent for the Somatostatin Receptor
2007
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
The Lessons of GIST—PET and PET/CT: A New Paradigm for Imaging
2008
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
2009 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
2007 StandoutNobel
Early Prediction of Response to Sunitinib After Imatinib Failure by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Gastrointestinal Stromal Tumor
2008
Monitoring cancer treatment with PET/CT: does it make a difference?
2007

Works of Isis Gayed being referenced

Comparison of Bone and 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography in the Evaluation of Bony Metastases in Lung Cancer
2003
Preserving Functional Lung Using Perfusion Imaging and Intensity-Modulated Radiation Therapy for Advanced-Stage Non–Small Cell Lung Cancer
2007
Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer
2008
The Impact of DaTscan in the Diagnosis of Parkinson Disease
2015
Timing for Repeated Treatment of Hyperthyroid Disease with Radioactive Iodine After Initial Treatment Failure
2001
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
2004
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
2005
Rankless by CCL
2026